Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system

被引:0
作者
Gao, Mingyang [1 ]
Huang, Xiaobing [2 ]
Gao, Shichun [1 ]
Wang, Sanbin [3 ]
Deng, Jianchuan [4 ]
Zhang, Yanqi [5 ]
Kong, Peiyan [1 ]
Zhang, Cheng [1 ]
Gao, Li [1 ]
Feng, Yimei [1 ]
Zhu, Lidan [1 ]
Liu, Jia [1 ]
Chen, Ting [1 ]
Yao, Han [1 ]
Wang, Lu [1 ]
Liu, Huanfeng [1 ]
Liu, Yuqing [1 ]
Zhao, Lu [1 ]
Zhang, Xi [1 ]
Gao, Lei [1 ]
机构
[1] Army Med Univ, Xinqiao Hosp, Med Ctr Hematol, State Key Lab Trauma & Chem Poisoning, Chongqing, Peoples R China
[2] Univ Elect Sci & Technol China, Sichuan Acad Med Sci & Sichuan Prov Peoples Hosp, Affiliated Hosp, Dept Hematol, Chengdu, Peoples R China
[3] 920th Hosp Joint Logist Support Force, Dept Hematol, Kunming, Peoples R China
[4] Chongqing Med Univ, Affiliated Hosp 2, Dept Hematol, Chongqing, Peoples R China
[5] Army Med Univ, Coll Mil Prevent Med, Dept Hlth Stat, Chongqing, Peoples R China
关键词
Severe aplastic anemia; Haploidentical; HSCT; Nomogram; Prognostic scoring system; BONE-MARROW-TRANSPLANTATION; DISEASE RISK INDEX; DIAGNOSIS; MANAGEMENT; VALIDATION; GUIDELINES; CRITERIA; BLOOD;
D O I
10.1007/s00277-024-06051-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years, great progress has been made in haploidentical hematopoietic stem cell transplantation (haplo-HSCT) treatment for hematological malignant diseases because of the advent of novel conditioning regimens, optimized graft manipulation, improved graft-versus-host disease (GVHD) prophylaxis, and advances in supportive care. Recent studies have shown very favorable outcomes in severe aplastic anemia (SAA) patients, with comparable outcomes to those of patients receiving immune suppressive therapy (IST) and allogeneic HSCT from a matched sibling donor (MSD) or matched unrelated donor (MUD). However, most of the previous studies relied on single-center data analyses, and the conditioning regimen, GVHD prophylaxis and supportive care used were relatively singular. We do not know whether there are differences in the survival of SAA patients after haplo-HSCT and MSD-HSCT under conditions involving different transplant centers, conditioning regimens and GVHD prophylaxis. This is a disease-specific, multicenter and retrospective study. We retrospectively studied 156 consecutive patients with SAA who underwent haplo-HSCT or MSD-HSCT at four transplant centers in China. The 5-year overall survival (OS) rate was 87.5% in the haplo-HSCT group and 89.7% in the MSD-HSCT group. The time to hematopoietic reconstitution, incidence of graft versus host disease, and infection and graft failure rates were not significantly different between the groups. Haplo-HSCT achieved outcomes comparable to those of MSD-HSCT for SAA patients. According to the nomogram score, we developed a SAA prognostic scoring system. Haplo-HSCT should be considered an effective alternative for patients with SAA without a matched sibling donor. The SAA transplant-specific prognostic scoring system proposed in this study can conveniently predict the OS for SAA patients following MSD-HSCT or haplo-HSCT.
引用
收藏
页码:781 / 791
页数:11
相关论文
共 39 条
[1]   Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA- Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation [J].
Alotaibi, Hind ;
Aljurf, Mahmoud ;
de Latour, Regis ;
Alfayez, Mansour ;
Bacigalupo, Andrea ;
El Fakih, Riad ;
Schrezenmeier, Hubert ;
Ahmed, Syed Osman ;
Gluckman, Eliane ;
Iqbal, Shahid ;
Hochsmann, Britta ;
Halkes, Constantijn ;
de la Fuente, Josu ;
Alshehry, Nawal ;
Cesaro, Simone ;
Passweg, Jakob ;
Dufour, Carlo ;
Risitano, Antonio M. ;
DiPersio, John ;
Motabi, Ibraheem .
TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (02) :105.e1-105.e7
[2]   Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation [J].
Armand, Philippe ;
Kim, Haesook T. ;
Logan, Brent R. ;
Wang, Zhiwei ;
Alyea, Edwin P. ;
Kalaycio, Matt E. ;
Maziarz, Richard T. ;
Antin, Joseph H. ;
Soiffer, Robert J. ;
Weisdorf, Daniel J. ;
Rizzo, J. Douglas ;
Horowitz, Mary M. ;
Saber, Wael .
BLOOD, 2014, 123 (23) :3664-3671
[3]   A disease risk index for patients undergoing allogeneic stem cell transplantation [J].
Armand, Philippe ;
Gibson, Christopher J. ;
Cutler, Corey ;
Ho, Vincent T. ;
Koreth, John ;
Alyea, Edwin P. ;
Ritz, Jerome ;
Sorror, Mohamed L. ;
Lee, Stephanie J. ;
Deeg, H. Joachim ;
Storer, Barry E. ;
Appelbaum, Frederick R. ;
Antin, Joseph H. ;
Soiffer, Robert J. ;
Kim, Haesook T. .
BLOOD, 2012, 120 (04) :905-913
[4]   How I treat acquired aplastic anemia [J].
Bacigalupo, Andrea .
BLOOD, 2017, 129 (11) :1428-1436
[5]   Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis [J].
Bacigalupo, Andrea ;
Socie, Gerard ;
Hamladji, Rose Marie ;
Aljurf, Mahmoud ;
Maschan, Alexei ;
Kyrcz-Krzemien, Slawomira ;
Chybicka, Alicja ;
Sengelov, Henrik ;
Unal, Ali ;
Beelen, Dietrich ;
Locasciulli, Anna ;
Dufour, Carlo ;
Passweg, Jakob R. ;
Oneto, Rosi ;
Signori, Alessio ;
Marsh, Judith C. W. .
HAEMATOLOGICA, 2015, 100 (05) :696-702
[6]   Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato-Oncology Italian Association (AIEOP) [J].
Barone, Angelica ;
Lucarelli, Annunziata ;
Onofrillo, Daniela ;
Verzegnassi, Federico ;
Bonanomi, Sonia ;
Cesaro, Simone ;
Fioredda, Fra. Ncesca ;
Iori, Anna Paola ;
Ladogana, Saverio ;
Locasciulli, Anna ;
Longoni, Daniela ;
Lanciotti, Marina ;
Macaluso, Alessandra ;
Mandaglio, Rosalba ;
Marra, Nicoletta ;
Martire, Baldo ;
Maruzzi, Matteo ;
Menna, Giuseppe ;
Notarangelo, Lucia Dora ;
Palazzi, Giovanni ;
Pillon, Marta ;
Ramenghi, Ugo ;
Russo, Giovanna ;
Svahn, Johanna ;
Timeus, Fabio ;
Tucci, Fabio ;
Cugno, Chiara ;
Zecca, Marco ;
Farruggia, Piero ;
Dufour, Carlo ;
Saracco, Paola .
BLOOD CELLS MOLECULES AND DISEASES, 2015, 55 (01) :40-47
[7]   Hematopoietic stem cell transplantation for patients with AML in first complete remission [J].
Cornelissen, Jan J. ;
Blaise, Didier .
BLOOD, 2016, 127 (01) :62-70
[8]   Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant [J].
Dufour, Carlo ;
Pillon, Marta ;
Socie, Gerard ;
Rovo, Alicia ;
Carraro, Elisa ;
Bacigalupo, Andrea ;
Oneto, Rosi ;
Passweg, Jakob ;
Risitano, Antonio ;
Tichelli, Andre ;
de Latour, Regis Peffault ;
Schrezenmeier, Hubert ;
Hocshmann, Britta ;
Peters, Christina ;
Kulasekararaj, Austin ;
Van Biezen, Anja ;
Samarasinghe, Sujith ;
Hussein, Ayad Ahmed ;
Ayas, Mouhab ;
Aljurf, Mahmoud ;
Marsh, Judith .
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) :565-573
[9]   Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAWP of EBMT) [J].
ElGohary, Ghada ;
El Fakih, Riad ;
de Latour, Regis ;
Risitano, Antonio ;
Marsh, Judith ;
Schrezenmeier, Hubert ;
Gluckman, Eliane ;
Hoechsmann, Britta ;
Pierri, Filomena ;
Halkes, Constantijn ;
Alzahrani, Hazzaa ;
De la Fuente, Josu ;
Cesaro, Simone ;
Alahmari, Ali ;
Ahmed, Syed Osman ;
Passweg, Jakob ;
Dufour, Carlo ;
Bacigalupo, Andrea ;
Aljurf, Mahmoud .
BONE MARROW TRANSPLANTATION, 2020, 55 (10) :1906-1917
[10]   Long-term outcome of HLA-haploidentical hematopoietic SCT without in vitro T-cell depletion for adult severe aplastic anemia after modified conditioning and supportive therapy [J].
Gao, L. ;
Li, Y. ;
Zhang, Y. ;
Chen, X. ;
Gao, L. ;
Zhang, C. ;
Liu, Y. ;
Kong, P. ;
Wang, Q. ;
Su, Y. ;
Wang, C. ;
Wang, S. ;
Li, B. ;
Sun, A. ;
Du, X. ;
Zeng, D. ;
Li, J. ;
Liu, H. ;
Zhang, X. .
BONE MARROW TRANSPLANTATION, 2014, 49 (04) :519-524